Critical Makeover China advances medical reform to substantially lower drug prices

下载PDF

导出

摘要 On February 3,representatives of over 100 pharmaceutical companies gathered in a hotel in Shanghai.With documents in hand,they were there to attend a centralized procurement session organized by China’s health authority.

作者 Hu Fan

机构地区不详

出处《ChinAfrica》 2021年第4期30-31,共2页 中国与非洲（英文版）

关键词 COMPANIES PRICES ADVANCES

分类号 F42 [经济管理—产业经济]

引文网络
相关文献

1Piao Huiling,Wei Xingchen,Wang Nan,Wang Xing,Zhou Yusheng,Dong Li.Current Effect of“4+7”Drug Centralized Volume Procurement and Suggestions for Future Improvement[J].Asian Journal of Social Pharmacy,2020,15(4):198-212.
2Kristi Abbott,Hui Shao,Lizheng Shi.Policy options for addressing the high cost of specialty pharmaceuticals[J].Global Health Journal,2019,3(4):79-83.
3戴素芬.基于身份的分层加密的组合文档安全删除方案[J].电脑与电信,2021(1):41-45. 被引量：1
4Richard Korsmeyer.Critical questions in development of targeted nanoparticle therapeutics[J].Regenerative Biomaterials,2016,3(2):143-147. 被引量：1
5Hongbin Wu,Ana Xie,Weimin Wang.Eight-Year Medical Education Program:Retrospect and Prospect of the High-Level Medical Talent Training in China[J].ECNU Review of Education,2021,4(1):190-209. 被引量：2
6Nosratollah Nafar.Global Income Inequality and Poverty Reduction:Trends and Remedies[J].Management Studies,2021,9(1):35-41.

ChinAfrica

2021年第4期

浏览历史

内容加载中请稍等...

Critical Makeover China advances medical reform to substantially lower drug prices

相关作者

相关机构

相关主题

浏览历史